Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
Abstract Epilepsy is a chronic neurological disorder that affects more than 50 million people worldwide. Despite a recent introduction of antiseizure drugs for the treatment of epileptic seizures, one‐third of these patients suffer from drug‐resistant epilepsy (DRE). The therapeutic target hypothesi...
Main Authors: | Daniel Fonseca‐Barriendos, Christian Lizette Frías‐Soria, Daniel Pérez‐Pérez, Rosenda Gómez‐López, Dasiel O. Borroto Escuela, Luisa Rocha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12539 |
Similar Items
-
Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs
by: Katarzyna Łukasiuk, et al.
Published: (2023-02-01) -
Neuronal autoantibodies in a sample of Egyptian patients with drug-resistant epilepsy
by: Hadeer Mohamed, et al.
Published: (2023-06-01) -
Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies
by: Guery D, et al.
Published: (2021-07-01) -
Neuropharmacology of Antiseizure Drugs
by: Tahir Hakami
Published: (2021-09-01) -
An online tool for information to women with epilepsy and therapeutic drug monitoring in pregnancy: Design and pilot study
by: Kristina Lisovska, et al.
Published: (2021-06-01)